SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
New Clinical Data on AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.)'s Tivozanib and Ficlatuzumab to be Presented at the ESMO 2012 Congress